In this short blog, Sarah Chapman looks at the evidence on treatments for vaginal thrush and what else might matter to you when looking for a treatment for it.
The evidence comes from three Cochrane Reviews by the Sexually Transmitted Infections Group* and is relevant to women with vaginal thrush, except women who are HIV positive, immunocompromised, pregnant, breastfeeding or have diabetes, as the research studies excluded them.
*The evidence comes from these Cochrane Reviews:
- Cooke G, Watson C, Deckx L, Pirotta M, Smith J, van Driel ML. Treatment for recurrent vulvovaginal candidiasis (thrush). Cochrane Database of Systematic Reviews 2022, Issue 1. Art. No.: CD009151
- Denison HJ, Worswick J, Bond CM, Grimshaw JM, Mayhew A, Gnani Ramadoss S, Robertson C, Schaafsma ME, Watson MC. Oral versus intra-vaginal imidazole and triazole anti‐fungal treatment of uncomplicated vulvovaginal candidiasis (thrush). Cochrane Database of Systematic Reviews 2020, Issue 8. Art. No.: CD002845
- Xie HY, Feng D, Wei DM, Mei L, Chen H, Wang X, Fang F. Probiotics for vulvovaginal candidiasis in non-pregnant women. Cochrane Database of Systematic Reviews 2017, Issue 11. Art. No.: CD010496